56 / 87
What are the positions
of LISI MEDICAL today?
In 2017, our division enjoyed a year of full swing activity
integrating the two sites of the U.S. company
LISI MEDICAL Remmele acquired the previous year.
In addition to the strong growth in sales revenue that
it brought about compared to 2016, this change in
scope now positions the division as one of the major
players in the markets for bone surgery and minimally
invasive surgery. This strategic acquisition also
allowed us to divide and balance our industrial
resources between two continents, while taking
advantage of the technological specificities of each
site. The sites in our former scope (Caen, Lyon, San
Diego) have experienced sustained activity and organic
growth in line with the progress of the market.
How do the synergies work?
As planned, LISI MEDICAL Remmele has completed
its integration plan with the deployment of the
LISI System’s three structuring programs, i.e. the
LISI Excellence Achievement Program (LEAP), E-HSE,
and COS (Controlling Operating System). This
experience revealed the desire to create synergies
between the different entities, both at the operational
and commercial levels. The industrial support and
purchasing functions, created in 2016, were able to
deploy a common vision and address projects that
have generated, and will still generate, gains for the
LISI MEDICAL division. The sales organization has
focused on allowing large customers to have a more
all-encompassing vision of the portfolio of products
and solutions offered by the division through its
various entities. With this in mind, central business
functions for the Americas and Europe have been
created to meet the overall demands expressed
by global customers.
What are the next steps?
The major customers in the field of the medical device
are looking for subcontractors capable of assisting
them in their growth, while mastering the quality and
cost of the products. It is therefore essential to
promote the general image of LISI MEDICAL in order
to capture the major projects from our customers,
but also to increase our capacities to meet these
needs. In 2017, we completed the 5,000 sq.m. and
3,700 sq.m. extensions of industrial premises at our
plants in Minneapolis (Big Lake) and Caen (Hérouville
Saint-Clair) respectively, while reorganizing the
production flows in accordance with LISI’s LEAP
method to achieve further efficiency gains.
“We meet the expectations of major
customers who are looking for
subcontractors capable of offering
an overall, global solution.”
LISI MEDICAL
3 QUESTIONS TO
OLIVIER LE BARS
CHIEF EXECUTIVE OFFICER, LISI MEDICAL
52
MARKETS & PRODUCTS